Results 191 to 200 of about 51,662 (290)
ABSTRACT Lymph node (LN) metastasis has been associated with shorter survival times in dogs with mast cell tumour (MCT), and treatment of metastatic LN with lymphadenectomy or irradiation has been demonstrated to improve outcomes. Identification of metastatic LN in dogs with MCT is therefore of both prognostic and therapeutic significance.
Alison C. Williams +5 more
wiley +1 more source
Machine learning-based prognostic model for human immunodeficiency virus-associated cutaneous T-cell lymphoma: A Surveillance, Epidemiology, and End Results database analysis. [PDF]
Huang W +7 more
europepmc +1 more source
Olfactory receptors as tumor suppressors in cutaneous T-cell lymphoma via p38γ pathway modulation. [PDF]
Zhang XH +9 more
europepmc +1 more source
Treatment of Reactive Histiocytosis With Oclacitinib: A Retrospective Case Series of 10 Dogs
Background: Canine reactive histiocytosis is a proliferative disorder of activated interstitial dendritic cells with cutaneous and systemic forms. An immune‐mediated aetiology is likely, and systemic immunomodulatory agents such as corticosteroids, tetracycline/niacinamide, ciclosporin, azathioprine and leflunomide have been employed for its management.
Christine L. Cain +2 more
wiley +1 more source
The notch sign as a clue for the diagnosis of early cutaneous T-cell lymphoma. [PDF]
Harkemanne E, Secco LP, Baeck M.
europepmc +1 more source
0994 Single-cell RNA sequencing reveals oncogenic drivers and markers of blood involvement in patients with cutaneous T-cell lymphoma [PDF]
January Weiner +3 more
openalex +1 more source
Abstract Recent studies highlight the important roles of cuproptosis in cancer cells. However, the roles of the cuproptosis‐related genes (CRGs) in different cancers are still not fully understood. Comprehensive analysis was performed using open‐source bioinformatic platforms to disclose the expression profiles, prognostic significance, genomic and ...
Xinyu Ge +10 more
wiley +1 more source
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma. [PDF]
Querfeld C +14 more
europepmc +1 more source

